In conjunction with the American Association for Pediatric Ophthalmology and Strabismus and the American Academy of Pediatrics
The Only Game in Town
Friday, Nov. 13
Sands Expo/Venetian, Las Vegas
Michael F. Chiang, MD and Gena Heidary, MD, PhD
Program Planning Group
Gil Binenbaum, MD; Michael F. Chiang, MD; Gena Heidary, MD, PhD; Jeffrey S. Hunter, MD; Scott A. Larson, MD; David G. Morrison, MD; Stacy L. Pineles, MD; and Deborah K. VanderVeen, MD
The 2020 Pediatric Ophthalmology Subspecialty Day meeting will promote a better understanding of specific pediatric ophthalmology and strabismus conditions, in the context of the whole patient, to facilitate better treatment outcomes. The program will provide participants with an understanding of newer developments in the field and an appreciation of the current challenges and controversies.
The intended target audience for this program includes pediatric ophthalmologists, strabismus specialists, comprehensive ophthalmologists, and orthoptists who are involved in maintaining high-quality health care for pediatric and strabismus populations.
The goals of this program are to:
- Provide attendees with a broad-based update on the diagnosis and management of pediatric ophthalmology and strabismus conditions and to improve outcomes.
- Update attendees on surgical options for complex strabismus and reoperations.
- Guide attendees in strategies for addressing retinopathy of prematurity.
- Update attendees on advances in ophthalmic genetics and gene therapy.
- Allow participants to understand and apply emerging approaches to childhood anterior segment disease.
- Update the audience on new imaging and testing modalities that they can use to improve their care of children with eye conditions and patients with strabismus.
This meeting will enable attendees to:
- Improve their ability to diagnose and manage pediatric ophthalmology, and strabismus conditions.
- Improve their outcomes in the management of pediatric ophthalmology and strabismus conditions.
- Understand recent advances in retinopathy of prematurity, ophthalmic genetics and gene therapy.
- Understand and apply emerging approaches to childhood anterior segment disease.
The American Academy of Ophthalmology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The American Academy of Ophthalmology designates this live activity for a maximum of 7 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Attendees registered as exhibitors, spouses and guests are not eligible for CME credits.
Find more information about CME.